Table 3.
Linear regression analyses between serum nesfatin-1 and other clinical parameters.
| Parameters | r | P value |
|---|---|---|
| Age (years) | 0.042 | 0.435 |
| Gender (M/F) | 0.077 | 0.148 |
| Family history of T2DM | 0.054 | 0.307 |
| Duration of T2DM (years) | −0.082 | 0.125 |
| BMI (Kg/m2) | −0.218 | <0.001 |
| SBP (mmHg) | 0.051 | 0.339 |
| DBP (mmHg) | 0.057 | 0.286 |
| TC (mmol/L) | −0.063 | 0.234 |
| TG (mmol/L) | −0.041 | 0.440 |
| LDL-C (mmol/L) | −0.085 | 0.112 |
| HDL-C (mmol/L) | 0.079 | 0.135 |
| FPG (mmol/L) | −0.050 | 0.344 |
| P2PG (mmol/L) | −0.028 | 0.600 |
| HbA1c (%) | −0.038 | 0.473 |
| HOMA-IR | −0.178 | 0.001 |
| CRP (mg/L) | −0.149 | 0.005 |
| ABI | 0.295 | <0.001 |